It has been revealed that F2RL2 can promote the tumorigenesis and immigration of breast cancer (44), indicating that these genes may serve as innovative biomarkers for early ESCC diagnosis. This evidence concerns the gene F2RL2 and esophageal squamous cell carcinoma.